Clinical trial

Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer

NCT03091842

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BEHAVIORAL · Unmapped registry intervention Exercise Intervention Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Informational Intervention Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Laboratory Biomarker Analysis Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Quality-of-Life Assessment Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Questionnaire Administration Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2019-07-29

PhaseNA

Conditions

Cancer Survivorunresolved

Central Obesityunresolved

Estrogen Receptor Positiveunresolved

Postmenopausalunresolved

Progesterone Receptor Positiveunresolved

Stage I Breast Cancerunresolved

Stage IA Breast Cancerunresolved

Stage IB Breast Cancerunresolved

Stage II Breast Cancerunresolved

Stage IIA Breast Cancerunresolved

Stage IIB Breast Cancerunresolved

Stage III Breast Cancerunresolved

Stage IIIA Breast Cancerunresolved

Stage IIIB Breast Cancerunresolved

Stage IIIC Breast Cancerunresolved

Interventions

Exercise InterventionBEHAVIORAL

Informational InterventionOTHER

Laboratory Biomarker AnalysisOTHER

Quality-of-Life AssessmentOTHER

Questionnaire AdministrationOTHER

Sponsors & collaborators

University of Southern Californialead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03091842 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.